UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 28, 2024 4:00 P.M.
Form:
F-1
CIK:
0001595353
Company Name:
Galmed Pharmaceuticals Ltd.
File Number:
333-282753